Bausch + Lomb Expands Note Offering to €675 Million

Bausch + Lomb Corporation ( (BLCO) ) has issued an announcement.

On June 18, 2025, Bausch + Lomb Corporation announced an increase in its offering of senior secured floating rate notes to €675 million, up from €600 million, with the proceeds intended to refinance existing loans and credit facilities. The company is also seeking to establish a $2.325 billion new term B loan facility and a new $800 million revolving credit facility, with both expected to close on June 26, 2025, to further strengthen its financial position.

The most recent analyst rating on (BLCO) stock is a Buy with a $18.00 price target. To see the full list of analyst forecasts on Bausch + Lomb Corporation stock, see the BLCO Stock Forecast page.

Spark’s Take on BLCO Stock

According to Spark, TipRanks’ AI Analyst, BLCO is a Neutral.

Bausch + Lomb’s overall score reflects solid revenue growth and a strong gross margin, but significant challenges in profitability and cash flow. Technical analysis shows bearish trends, while valuation metrics indicate poor earnings performance. The earnings call provided some optimism with growth in key segments, though risks remain from Pharmaceuticals and tariff pressures.

To see Spark’s full report on BLCO stock, click here.

More about Bausch + Lomb Corporation

Bausch + Lomb is a leading global eye health company dedicated to enhancing vision with a comprehensive portfolio of approximately 400 products, including contact lenses, lens care products, eye care products, ophthalmic pharmaceuticals, over-the-counter products, and ophthalmic surgical devices. Founded in 1853, the company has a significant global presence with around 13,500 employees and operations in approximately 100 countries, headquartered in Vaughan, Ontario.

Average Trading Volume: 876,285

Technical Sentiment Signal: Sell

Current Market Cap: $4.31B

For detailed information about BLCO stock, go to TipRanks’ Stock Analysis page.